Susi Zhu
Xiangya Road #87
Changsha, 410008, China
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeted Induction of Cancer Cell Necroptosis Potentiates Anti-PD-1 Immunotherapy via CD80 Activation.
Journal: International journal of biological sciences
Published: July 15, 2025
BLK suppresses melanoma progression and improves prognosis via pyroptosis regulation.
Journal: Scientific reports
Published: July 13, 2025
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 23, 2025
Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance.
Journal: Cell death & disease
Published: January 23, 2025
Ubiquitination in cancer: mechanisms and therapeutic opportunities.
Journal: Cancer communications (London, England)
Published: December 06, 2024
TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway.
Journal: MedComm
Published: December 30, 2022
NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signaling pathway.
Journal: Frontiers of medicine
Published: January 23, 2022
The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma.
Journal: Cancer cell international
Published: March 19, 2021
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
Journal: Cancer letters
Published: August 15, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026